Long non-coding RNAs in development and disease: conservation to mechanisms

被引:142
|
作者
Tsagakis, Ioannis [1 ,2 ]
Douka, Katerina [1 ,2 ]
Birds, Isabel [1 ,2 ]
Aspden, Julie L. [1 ,2 ]
机构
[1] Univ Leeds, Sch Mol & Cellular Biol, Fac Biol Sci, Leeds LS2 9JT, W Yorkshire, England
[2] Univ Leeds, LeedsOm, Leeds, W Yorkshire, England
来源
JOURNAL OF PATHOLOGY | 2020年 / 250卷 / 05期
基金
英国生物技术与生命科学研究理事会;
关键词
long non-coding RNA; long intergenic non-coding RNA; anti-sense lncRNAs; translation; conservation; stem cells; development; X chromosome inactivation; neurodegenerative disease; cancer; diabetes; XIST RNA; CHROMOSOMAL LOCALIZATION; NUCLEAR-LOCALIZATION; BC200; RNA; HNRNP U; GENE; EXPRESSION; TRANSLATION; EVOLUTION; CANCER;
D O I
10.1002/path.5405
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Our genomes contain the blueprint of what makes us human and many indications as to why we develop disease. Until the last 10 years, most studies had focussed on protein-coding genes, more specifically DNA sequences coding for proteins. However, this represents less than 5% of our genomes. The other 95% is referred to as the 'dark matter' of our genomes, our understanding of which is extremely limited. Part of this 'dark matter' includes regions that give rise to RNAs that do not code for proteins. A subset of these non-coding RNAs are long non-coding RNAs (lncRNAs), which in particular are beginning to be dissected and their importance to human health revealed. To improve our understanding and treatment of disease it is vital that we understand the molecular and cellular function of lncRNAs, and how their misregulation can contribute to disease. It is not yet clear what proportion of lncRNAs is actually functional; conservation during evolution is being used to understand the biological importance of lncRNA. Here, we present key themes within the field of lncRNAs, emphasising the importance of their roles in both the nucleus and the cytoplasm of cells, as well as patterns in their modes of action. We discuss their potential functions in development and disease using examples where we have the greatest understanding. Finally, we emphasise why lncRNAs can serve as biomarkers and discuss their emerging potential for therapy. (c) 2020 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of Pathological Society of Great Britain and Ireland.
引用
收藏
页码:480 / 495
页数:16
相关论文
共 50 条
  • [21] Long non-coding RNAs as emerging regulators of differentiation, development, and disease
    Dey, Bijan K.
    Mueller, Adam C.
    Dutta, Anindya
    TRANSCRIPTION-AUSTIN, 2014, 5 (04):
  • [23] Non-coding RNAs in disease: from mechanisms to therapeutics
    Nemeth, Kinga
    Bayraktar, Recep
    Ferracin, Manuela
    Calin, George A.
    NATURE REVIEWS GENETICS, 2024, 25 (03) : 211 - 232
  • [24] Non-coding RNAs in disease: from mechanisms to therapeutics
    Kinga Nemeth
    Recep Bayraktar
    Manuela Ferracin
    George A. Calin
    Nature Reviews Genetics, 2024, 25 : 211 - 232
  • [25] Evolutionary conservation of long non-coding RNAs in non-alcoholic fatty liver disease
    Rohilla, Sumati
    Awasthi, Ankita
    Kaur, Savneet
    Puria, Rekha
    LIFE SCIENCES, 2021, 264
  • [26] The Advancement of Long Non-Coding RNAs in Cholangiocarcinoma Development
    Jiang, Fengru
    Ling, Xiaofeng
    JOURNAL OF CANCER, 2019, 10 (11): : 2407 - 2414
  • [27] Long non-coding RNAs in chondrocyte development and cartilage
    Barter, M. J.
    Gomez, R.
    Hyatt, S.
    Xu, Y.
    Young, D. A.
    INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, 2015, 96 (02) : A22 - A22
  • [28] Roles for long non-coding RNAs in physiology and disease
    Maria-Theodora Melissari
    Phillip Grote
    Pflügers Archiv - European Journal of Physiology, 2016, 468 : 945 - 958
  • [29] Long Non-coding RNAs in Parkinson's Disease
    Xin, Chengqi
    Liu, Jing
    NEUROCHEMICAL RESEARCH, 2021, 46 (05) : 1031 - 1042
  • [30] Long non-coding RNAs in vascular biology and disease
    Jae, Nicolas
    Heumueller, Andreas W.
    Fouani, Youssef
    Dimmeler, Stefanie
    VASCULAR PHARMACOLOGY, 2019, 114 : 13 - 22